Hepatitis Awareness Month 2018: Three Reasons Why It’s Important to Get Tested

May 17, 2018 | Sarah Getachew

Across the United States approximately 1.2 million people are living with chronic hepatitis B virus (HBV) and an estimated 3.5 million are living with chronic hepatitis C virus (HCV). Given the limited surveillance capacity of state and local health departments, these numbers most likely underestimate HBV and HCV prevalence. National Hepatitis Testing Day, which takes place on Saturday, May 19th, presents a great opportunity to raise awareness and remind community members and healthcare providers about the importance of testing.

Here are three reasons why it’s important to get tested:

  1. Viral hepatitis is a silent epidemic. Although HBV and HCV are leading causes of liver cancer-related death and claim the lives of over 20,000 people in the U.S. each year, viral hepatitis remains virtually unknown to many members of the general public, at-risk populations, policymakers, and even healthcare providers. Many people living with viral hepatitis do not know that they are infected, placing them at greater risk for complications from the disease and increased likelihood of spreading it to others. Also, many people with chronic HBV and HCV do not experience symptoms and therefore never seek medical attention. In fact, 65% of people living with chronic HBV and nearly half of all people living with chronic HCV do not know they are infected. The only way to know if you have viral hepatitis is to get tested!
  2. Hepatitis testing can save your life. Lifesaving, FDA-approved antiviral therapies are available to treat chronic HBV and new treatments are available that can cure HCV. Current available treatment for HCV can cure over 90% of people living with HCV within 8-12 weeks of starting oral therapy. Due to the asymptomatic nature of chronic HBV and HCV, early detection and treatment is crucial to prevent individuals from developing long-term liver damage and avoid liver cancer.
  3. Hepatitis testing is recommended for certain priority populations. Certain populations are at a higher risk of contracting hepatitis A virus (HAV), HBV or HCV. The ABCs of Hepatitis, an informational document created by the Centers for Disease Control and Prevention, describes routes of hepatitis transmission, populations at high risk for HAV, HBV and HCV, and hepatitis screening recommendations for chronic (lifelong) infection. HAV does not progress into a chronic infection but HBV and HCV can cause chronic infection, scarring of the liver, liver cancer, liver failure, and death.

Medicare covers one HCV screening test and yearly repeat screenings for populations at high risk, including:

  • People who currently inject drugs, or who have done so in the past;
  • People with certain medical conditions, including those who: received clotting factor concentrates produced before 1987; were ever on long-term hemodialysis; are living with HIV; were recipients of blood transfusions or organ transplants;
  • Healthcare, emergency medical, and public safety workers who’ve been exposed to HCV-positive blood; and
  • Children born to HCV-positive women.

Medicare also covers an HBV screening tests for asymptomatic, nonpregnant adolescents and adults at high risk for HBV and a screening test at the first prenatal visit for pregnant women and then rescreening at time of delivery for those with new or continuing risk factors.

It’s likely that there are people in your community are unsure if they should be tested – encourage these individuals to take CDC’s Hepatitis Risk Assessment for a personalized risk assessment report.

Get Involved!

Local health departments play a critical role in educating community members about viral hepatitis, offering or referring people to testing, and providing or linking people to care. Throughout this month, NACCHO encourages our members to make an extra effort to raise awareness about hepatitis. Here’s some ways to get involved:

Together, we can put an end to this silent epidemic!


About Sarah Getachew

More posts by Sarah Getachew

Related Posts

1
  • Emergency Response
  • Maternal, Child, & Adolescent Health

Building Community Resilience Through Maternal and Child...

NACCHO, with funding from the Centers for Disease Control and Prevention’s...

Mar 15, 2024 | Elana Filipos

Building Community Resilience Through Maternal and Child...

  • HIV, STI, & Viral Hepatitis

CDC Study Reveals Increase in Overdoses Associated with...

A recent CDC study demonstrates a need for LHDs and other local harm reduction...

Mar 14, 2024 | Kat Kelley, Anjana Rao, Grace Murtha

CDC Study Reveals Increase in Overdoses Associated with...

1
  • Emergency Response
  • Maternal, Child, & Adolescent Health

Bridging Maternal-Child Health (MCH), Infectious Disease...

Funded through the Center for Disease Control and Prevention’s (CDC) National...

Mar 12, 2024 | Elana Filipos

Bridging Maternal-Child Health (MCH), Infectious Disease...

Thumbnail youtube
  • Tools & Resources
  • Adverse Childhood Experiences (ACEs)

NACCHO Releases “Community Partnerships to Prevent...

The National Association of County and City Health Officials is pleased to...

Mar 12, 2024 | Camille Adams

NACCHO Releases “Community Partnerships to Prevent...

1
  • Maternal, Child, & Adolescent Health

NACCHO Provides Funding to Local Health Departments to...

The Maternal, Child, and Adolescent Health team has selected 14 new local...

Mar 11, 2024 | Ryanna Quazi

NACCHO Provides Funding to Local Health Departments to...

NACCHO Cognitive Health Guide FINAL 1
  • Tools & Resources
  • Healthy Aging
  • Healthy Living & Prevention
  • Mobilizing for Action through Planning and Partnerships (MAPP)

New NACCHO Resource: Integrating Brain Health into...

NACCHO, in partnership with the Alzheimer’s Association, is thrilled to launch...

Mar 01, 2024 | Andrea Grenadier

New NACCHO Resource: Integrating Brain Health into...

  • HIV, STI, & Viral Hepatitis
  • HIV, STI, Viral Hepatitis, and Harm Reduction Digest

Digest (February 28, 2024)

HIV, STI, Viral Hepatitis, and Harm Reduction Digest: February 28, 2024

Mar 01, 2024

Digest (February 28, 2024)

EHE Superstars Investing in Community Voices in LA County
  • HIV, STI, & Viral Hepatitis

EHE Superstars: Investing in Community Voices in LA...

This blog continues our new series highlighting collaborative projects between...

Feb 28, 2024 | Anthony Green

EHE Superstars: Investing in Community Voices in LA...

I Stock 1490413668
  • Emergency Response
  • Maternal, Child, & Adolescent Health

Announcing NACCHO’s 2023-2024 Virtual Learning...

NACCHO, with support from the Centers for Disease Control and Prevention’s...

Feb 16, 2024 | Harpur Schwartz, Elana Filipos

Announcing NACCHO’s 2023-2024 Virtual Learning...

Back to Top